US Drug Supply Chain

The security of the pharmaceutical supply chain is vital to protecting the public health. We have embarked on many endeavors to help ensure the security and integrity of the supply chain. 

Protecting the Drug Supply Chain

Following the final rule approved by the Trump Administration and published by Food and Drug Administration in 2020, states can now submit proposals to establish their own wholesale prescription drug importation program from Canada. While we understand the desire to decrease the costs of prescription drugs, states may face challenges while ensuring patient safety and securing the global supply chain.

Continuing the presidential initiative of former NABP President Caroline D. Juran, BSPharm, DPH (Hon) we have worked to support the boards of pharmacy and educate and protect the public about state drug importation plans by: 

Additional Resources

Increasing awareness about state importation programs is necessary to maintain patient safety. More information about prescription drug importation can be found in the below resources. 

Pulse by NABP

Following the passing of the Drug Supply Chain Security Act in 2013, a 10-year timeline was established for full implementation of a set of requirements, including electronic, interoperable product tracing at the package level, across the pharmaceutical supply chain. With the final deadline approaching in November, in early 2023 we announced our solution for the supply chain: Pulse by NABPTM

Pulse is an inclusive, accessible, and secure digital platform that simplifies the process of achieving DSCSA compliance. Launching this Summer, Pulse will provide access to user-friendly tools and a comprehensive network of verified relationships, enabling consistent communication with trusted partners across the supply chain from manufacturers to dispensers.

Learn more about Pulse.